Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by nikkeron Nov 30, 2016 4:17pm

62 Views

Post# 25536370

Trades

Recent Trades - Last 10 of 275 Time ET Ex Price Change Volume Buyer Seller Markers 15:59:08 C 0.15 89 2 RBC 36 Latimer 15:59:08 C 0.15 6,500 2 RBC 1 Anonymous 15:59:03 C 0.15 1,500 1 Anonymous 1 Anonymous 15:58:46 C 0.15 1,500 85 Scotia 1 Anonymous 15:58:21 C 0.145 -0.005 22,000 7 TD Sec 1 Anonymous 15:58:21 C 0.145 -0.005 10,000 85 Scotia 1 Anonymous 15:58:21 C 0.145 -0.005 7,000 2 RBC 1 Anonymous 15:58:21 C 0.145 -0.005 100,000 68 Leede 1 Anonymous 15:58:21 C 0.145 -0.005 1,500 7 TD Sec 1 Anonymous 15:58:21 C 0.145 -0.005 1,500 2 RBC 1 Anonymous

Bullboard Posts

POET increases production capacity to meet AI demand